SMAD3 and pulmonary fibrosis: For instance, Sirt1 activation or overexpression can inhibit pulmonary fibrosis in vitro via inactivation of TGF-β1/Smad3 and mTOR signaling (Warburton et al., 2013; Chu et al., 2018).